My Treatment Approach: Metastatic Triple-Negative Breast Cancer

home / insights / my-treatment-approach-metastatic-triple-negative-breast-cancer

Expert oncologists center discussion on a clinical scenario to highlight optimal treatment strategies in metastatic triple-negative breast cancer.

Experts on TNBC

EP. 1: Perspectives on the Current Treatment Landscape of TNBC

Sara A. Hurvitz, MD, University of California, Los Angeles;Gregory Vidal, MD, PhD
July 18th 2022

Expert oncologists share insight on the prognosis of triple-negative breast cancer (TNBC) and broadly review current treatment options for patients.

Experts on TNBC

EP. 2: Clinical Scenario: mTNBC Treated With Chemotherapy Then Sacituzumab Govitecan

Sara A. Hurvitz, MD, University of California, Los Angeles;Gregory Vidal, MD, PhD
July 18th 2022

After reviewing a patient scenario of relapsed/refractory metastatic TNBC, expert oncologists elucidate use of sacituzumab govitecan in this setting.

Experts on TNBC

EP. 3: Metastatic TNBC: Safety, Efficacy, and Quality of Life With Sacituzumab Govitecan

Sara A. Hurvitz, MD;Gregory Vidal, MD, PhD
July 25th 2022

Comprehensive discussion on the safety and efficacy profile of the antibody-drug conjugate (ADC) sacituzumab govitecan and managing ADC-related adverse events in patients with mTNBC.

Experts on TNBC

EP. 4: Novel ADCs Under Investigation in Triple-Negative Breast Cancer

Sara A. Hurvitz, MD;Gregory Vidal, MD, PhD
July 25th 2022

Expert oncologists review novel ADCs in TNBC and consider how their approval may impact sequencing of therapy in this setting.

Experts on breast cancer

EP. 5: Addressing Unmet Needs in the Management of TNBC

Sara A. Hurvitz, MD;Gregory Vidal, MD, PhD
August 2nd 2022

Perspectives on the most prominent unmet needs in metastatic triple-negative breast cancer and how these may be addressed with future clinical trials.

Experts on breast cancer

EP. 6: Practical Advice on the Management of TNBC

Sara A. Hurvitz, MD;Gregory Vidal, MD, PhD
August 2nd 2022

Before closing out their conversation on metastatic triple-negative breast cancer, expert oncologists share a few clinical pearls on optimizing TNBC management.